Learn how to beat the pros

From Oxford Club | Ad

Hedge funds and billionaires have pushed around Main Street investors for long enough. In honor of this radical shift…I'm going to make my most popular manual "5 Secret Trading Strategies to Win Every Day in the Market" available for FREE for anyone who wants it.

Click here to download your copy

LJPC Insider Trading (La Jolla Pharmaceutical)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 33.39%

Insider Buying (Last 12 Months): $3,544,537.68

Insider Selling (Last 12 Months): $0.00

La Jolla Pharmaceutical Insider Trading History Chart

La Jolla Pharmaceutical Share Price & Price History

^$5.12

▲ +0.09 (1.79%)

As of 06/11/2021 01:00 AM ET

Days: 30 | 90 | 365

The 32-Second Options Trading "Training Video"

From Legacy- JCF Campaigns | Ad

Watch his 32-second options trading "training video" here.

La Jolla Pharmaceutical Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/1/2021	Kevin C Tang	Director	Buy	59,092	$4.47	$264,141.24
5/27/2021	Kevin C Tang	Director	Buy	185,928	$4.47	$831,098.16
5/24/2021	David A Ramsay	Director	Buy	20,000	$3.49	$69,800.00	51,000
9/8/2020	Kevin C Tang	Director	Buy	84,152	$3.90	$328,192.80
9/4/2020	Kevin C Tang	Director	Buy	67,552	$3.82	$258,048.64
8/24/2020	David A Ramsay	Director	Buy	47,000	$3.99	$187,530.00
8/14/2020	Kevin C Tang	Director	Buy	431,647	$3.72	$1,605,726.84
6/4/2020	Kevin C Tang	Director	Buy	615,129	$5.01	$3,081,796.29
6/2/2020	Kevin C Tang	Director	Buy	253,553	$4.88	$1,237,338.64
2/3/2020	Kevin C Tang	Director	Buy	75,003	$6.80	$510,020.40
1/30/2020	Kevin C Tang	Director	Buy	81,475	$6.72	$547,512.00
1/14/2020	Darryl Wellinghoff	Insider	Buy	3,000	$8.23	$24,690.00	6,545
1/13/2020	Kevin C Tang	Director	Buy	2,971,682	$7.00	$20,801,774.00
1/9/2020	Kevin C Tang	Director	Buy	1,000,000	$4.99	$4,990,000.00
1/30/2019	Lakhmir S Chawla	Insider	Buy	3,000	$5.56	$16,680.00	3,059
1/9/2019	James Rolke	Insider	Buy	1,600	$6.09	$9,744.00	75,030
1/9/2019	Jennifer Carver	COO	Buy	5,000	$6.17	$30,850.00	7,632
1/9/2019	Kevin C Tang	Director	Buy	1,300,000	$5.37	$6,981,000.00
1/8/2019	Life Sciences Maste Perceptive	Major Shareholder	Sell	2,060,235	$5.69	$11,722,737.15
1/7/2019	George F Tidmarsh	CEO	Buy	2,000	$5.85	$11,700.00	1,281,408
1/7/2019	Kevin C Tang	Director	Buy	100,000	$5.84	$584,000.00
8/16/2018	Jennifer Carver	COO	Buy	1,000	$20.90	$20,900.00	6,500

SEC Filings (Institutional Ownership Changes) for La Jolla Pharmaceutical (NASDAQ:LJPC)

74.89% of La Jolla Pharmaceutical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

La Jolla Pharmaceutical Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/19/2021	Virtu Financial LLC	11,843	$50K	0.0%	-62.1%	0.043%
5/19/2021	Squarepoint Ops LLC	33,988	$0.14M	0.0%	N/A	0.124%
5/18/2021	Millennium Management LLC	175,836	$0.75M	0.0%	N/A	0.641%
5/18/2021	D. E. Shaw & Co. Inc.	731,137	$3.10M	0.0%	+75.9%	2.664%
5/18/2021	Morgan Stanley	427,683	$1.81M	0.0%	+5.5%	1.558%
5/18/2021	Cubist Systematic Strategies LLC	16,218	$69K	0.0%	N/A	0.059%
5/18/2021	Jane Street Group LLC	11,173	$47K	0.0%	N/A	0.041%
5/17/2021	Schonfeld Strategic Advisors LLC	16,200	$68K	0.0%	N/A	0.059%
5/17/2021	PDT Partners LLC	10,809	$46K	0.0%	N/A	0.039%
5/17/2021	Nuveen Asset Management LLC	146,256	$0.62M	0.0%	-8.1%	0.533%
5/17/2021	Goldman Sachs Group Inc.	137,650	$0.58M	0.0%	+11.1%	0.501%
5/14/2021	RTW Investments LP	2,327,903	$9.87M	0.2%	-2.9%	8.481%
5/14/2021	Occudo Quantitative Strategies LP	18,113	$77K	0.0%	N/A	0.066%
5/13/2021	Trexquant Investment LP	25,006	$0.11M	0.0%	N/A	0.091%
5/13/2021	Barclays PLC	15,083	$64K	0.0%	+158.6%	0.055%
5/13/2021	Renaissance Technologies LLC	33,600	$0.14M	0.0%	-74.1%	0.122%
5/13/2021	Bank of New York Mellon Corp	120,348	$0.51M	0.0%	+84.0%	0.438%
5/12/2021	Northern Trust Corp	228,088	$0.97M	0.0%	-8.9%	0.831%
5/12/2021	Geode Capital Management LLC	416,587	$1.77M	0.0%	+3.7%	1.518%
5/12/2021	Premier Asset Management LLC	51,305	$0.22M	0.0%	-33.3%	0.187%
5/12/2021	JPMorgan Chase & Co.	83,632	$0.36M	0.0%	+26.7%	0.305%
5/11/2021	Acadian Asset Management LLC	114,946	$0.49M	0.0%	N/A	0.419%
5/7/2021	BlackRock Inc.	1,498,887	$6.36M	0.0%	+1.4%	5.462%
4/29/2021	Hollencrest Capital Management	39,000	$0.17M	0.0%	-20.4%	0.142%
4/15/2021	First Midwest Bank Trust Division	89,341	$0.38M	0.1%	-42.7%	0.326%
4/14/2021	WealthTrust Axiom LLC	30,400	$0.13M	0.0%	N/A	0.111%
2/26/2021	RMR Wealth Builders	9,400	$36K	0.0%	-56.1%	0.034%
2/24/2021	Virtu Financial LLC	31,227	$0.12M	0.0%	N/A	0.114%
2/24/2021	Alyeska Investment Group L.P.	536,847	$2.08M	0.0%	+9.3%	1.961%
2/19/2021	JPMorgan Chase & Co.	66,022	$0.26M	0.0%	-9.6%	0.241%
2/16/2021	Walleye Capital LLC	17,901	$69K	0.0%	N/A	0.065%
2/16/2021	Alyeska Investment Group L.P.	536,847	$2.08M	0.0%	+9.3%	1.961%
2/16/2021	Nuveen Asset Management LLC	159,107	$0.62M	0.0%	+16.5%	0.581%
2/11/2021	Northern Trust Corp	250,427	$0.97M	0.0%	-8.6%	0.915%
2/11/2021	Signaturefd LLC	10,000	$39K	0.0%	-54.5%	0.037%
2/10/2021	Renaissance Technologies LLC	129,953	$0.50M	0.0%	+1,070.7%	0.475%
2/9/2021	Wells Fargo & Company MN	26,253	$0.10M	0.0%	-39.0%	0.096%
2/9/2021	Bank of New York Mellon Corp	65,423	$0.25M	0.0%	-3.8%	0.239%
2/5/2021	BlackRock Inc.	1,477,499	$5.73M	0.0%	+2.5%	5.396%
1/26/2021	Hollencrest Capital Management	49,000	$0.19M	0.0%	+25.6%	0.179%
1/14/2021	First Midwest Bank Trust Division	155,845	$0.61M	0.1%	+431.2%	0.569%
11/17/2020	Tang Capital Management LLC	9,405,490	$37.90M	6.9%	+8.2%	34.350%
11/17/2020	California State Teachers Retirement System	27,276	$0.11M	0.0%	-15.4%	0.100%
11/16/2020	Squarepoint Ops LLC	12,998	$52K	0.0%	N/A	0.047%
11/13/2020	Morgan Stanley	894,685	$3.61M	0.0%	+34.0%	3.268%
11/13/2020	Charles Schwab Investment Management Inc.	189,785	$0.77M	0.0%	-31.8%	0.694%
11/12/2020	JPMorgan Chase & Co.	73,019	$0.29M	0.0%	-8.8%	0.267%
11/10/2020	State Street Corp	408,031	$1.64M	0.0%	+0.6%	1.491%
11/6/2020	BlackRock Inc.	1,441,302	$5.81M	0.0%	-3.5%	5.268%
10/13/2020	Hollencrest Capital Management	39,000	$0.16M	0.0%	+39.3%	0.143%
10/7/2020	Powell Investment Advisors LLC	12,000	$48K	0.0%	N/A	0.044%
9/15/2020	Two Sigma Advisers LP	375,223	$1.60M	0.0%	N/A	1.371%
9/4/2020	Principal Financial Group Inc.	47,508	$0.20M	0.0%	N/A	0.174%
8/25/2020	Nuveen Asset Management LLC	129,347	$0.55M	0.0%	+52.5%	0.473%
8/24/2020	FMR LLC	100,985	$0.43M	0.0%	-92.0%	0.369%
8/20/2020	Charles Schwab Investment Management Inc.	278,154	$1.19M	0.0%	+106.9%	1.017%
8/19/2020	RMR Wealth Builders	10,100	$43K	0.0%	N/A	0.037%
8/17/2020	AQR Capital Management LLC	23,081	$98K	0.0%	+64.0%	0.084%
8/17/2020	Engineers Gate Manager LP	52,700	$0.23M	0.0%	+95.9%	0.193%
8/17/2020	Jacobs Levy Equity Management Inc.	106,646	$0.45M	0.0%	+32.9%	0.390%
8/14/2020	RTW Investments LP	2,374,952	$10.12M	0.3%	+0.9%	8.680%
8/14/2020	Alyeska Investment Group L.P.	351,425	$1.50M	0.0%	N/A	1.284%
8/14/2020	Advisor Group Holdings Inc.	8,550	$37K	0.0%	-64.3%	0.031%
8/13/2020	FMR LLC	100,985	$0.43M	0.0%	-92.0%	0.369%
8/12/2020	Goldman Sachs Group Inc.	35,553	$0.15M	0.0%	+67.7%	0.130%
8/12/2020	Prudential Financial Inc.	46,880	$0.20M	0.0%	N/A	0.171%
8/12/2020	California Public Employees Retirement System	42,200	$0.18M	0.0%	+32.3%	0.154%
8/7/2020	Virtu Financial LLC	22,411	$95K	0.0%	N/A	0.082%
8/5/2020	Principal Financial Group Inc.	47,508	$0.20M	0.0%	N/A	0.174%
8/4/2020	Essex Investment Management Co. LLC	231,333	$0.99M	0.2%	N/A	0.847%
7/31/2020	UBS Group AG	19,845	$84K	0.0%	-24.8%	0.073%
7/30/2020	Signaturefd LLC	22,000	$94K	0.0%	N/A	0.081%
7/24/2020	Dupont Capital Management Corp	46,118	$0.20M	0.0%	N/A	0.169%
7/16/2020	Hollencrest Capital Management	28,000	$0.12M	0.0%	+180.0%	0.103%
7/16/2020	Wedbush Securities Inc.	15,000	$64K	0.0%	N/A	0.055%
6/19/2020	State Street Corp	409,448	$1.72M	0.0%	-4.6%	1.500%
6/16/2020	Royal Bank of Canada	15,608	$65K	0.0%	-22.0%	0.057%
5/26/2020	Morgan Stanley	638,120	$2.68M	0.0%	+67.1%	2.338%
5/18/2020	Tang Capital Management LLC	8,080,345	$33.94M	4.8%	+63.6%	29.598%
5/18/2020	Advisor Group Holdings Inc.	23,920	$0.10M	0.0%	N/A	0.088%
5/15/2020	AQR Capital Management LLC	14,075	$59K	0.0%	N/A	0.052%
5/15/2020	Engineers Gate Manager LP	26,900	$0.11M	0.0%	N/A	0.099%
5/15/2020	Morgan Stanley	638,120	$2.68M	0.0%	+67.1%	2.338%
5/15/2020	Two Sigma Investments LP	72,791	$0.31M	0.0%	N/A	0.267%
5/14/2020	Geode Capital Management LLC	315,278	$1.32M	0.0%	-10.0%	1.155%
5/14/2020	Deutsche Bank AG	46,996	$0.20M	0.0%	+130.0%	0.172%
5/14/2020	Nuveen Asset Management LLC	84,797	$0.36M	0.0%	+9.9%	0.311%
5/13/2020	Parametric Portfolio Associates LLC	22,394	$94K	0.0%	-31.5%	0.082%
5/13/2020	BNP Paribas Arbitrage SA	6,372	$27K	0.0%	+112.8%	0.023%
5/12/2020	Spark Investment Management LLC	51,500	$0.22M	0.1%	-51.1%	0.189%
5/12/2020	JPMorgan Chase & Co.	92,911	$0.39M	0.0%	-15.7%	0.340%
5/11/2020	Acadian Asset Management LLC	28,449	$0.12M	0.0%	-31.7%	0.104%
5/11/2020	State Street Corp	409,448	$1.72M	0.0%	-4.6%	1.500%
5/7/2020	Premier Asset Management LLC	29,865	$0.13M	0.1%	N/A	0.109%
5/1/2020	BlackRock Inc.	1,551,354	$6.52M	0.0%	-1.5%	5.700%
5/1/2020	UBS Group AG	26,406	$0.11M	0.0%	-14.7%	0.097%
4/29/2020	First Midwest Bank Trust Division	130,158	$0.55M	0.1%	N/A	0.478%
3/5/2020	Nuveen Asset Management LLC	77,178	$0.30M	0.0%	-7.9%	0.284%
3/3/2020	RMR Wealth Builders	7,800	$31K	0.0%	N/A	0.029%
2/20/2020	Geode Capital Management LLC	350,261	$1.38M	0.0%	+2.5%	1.290%

Data available starting January 2016

La Jolla Pharmaceutical Company engages in the development and commercialization of therapies that improve outcomes in patients suffering from life-threatening diseases. The company offers GIAPREZA, a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock; and XERAVA, a tetracycline class antibacterial indicated for the treatment of complicated intra-abdominal infections in patients 18 years of age and older. It offers GIAPREZA and XERAVA to hospitals and other healthcare organizations in the United States. Its product candidates that are in early stage clinical or preclinical development include TP-6076, an IV formulation of a fully synthetic fluorocycline derivative for the treatment of certain multidrug-resistant gram-negative bacteria; TP-271, an IV and oral formulation of a fully synthetic fluorocycline for the treatment of respiratory disease caused by bacterial biothreat and antibiotic-resistant public health pathogens, as well as bacterial pathogens associated with community-acquired bacterial pneumonia; and TP-2846, an IV formulation of a tetracycline for the treatment of acute myeloid leukemia. The company was incorporated in 1989 and is headquartered in San Diego, California.

Today's Range

Now: $5.12

$4.87

$5.15

50 Day Range

MA: $4.19

$3.46

$5.20

52 Week Range

Now: $5.12

$3.35

$7.85

Volume

232,928 shs

Average Volume

667,220 shs

Market Capitalization

$140.65 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.36

Who are the company insiders with the largest holdings of La Jolla Pharmaceutical?

La Jolla Pharmaceutical's top insider shareholders include:

David A Ramsay (Director)
Darryl Wellinghoff (Insider)
Kevin C Tang (Director)

Who are the major institutional investors of La Jolla Pharmaceutical?

La Jolla Pharmaceutical's top institutional investors include:

RTW Investments LP — 8.48%
BlackRock Inc. — 5.46%
D. E. Shaw & Co. Inc. — 2.66%
Morgan Stanley — 1.56%
Geode Capital Management LLC — 1.52%
Northern Trust Corp — 0.83%

Which institutional investors are selling La Jolla Pharmaceutical stock?

In the last quarter, LJPC stock was sold by these institutional investors:

Renaissance Technologies LLC
RTW Investments LP
First Midwest Bank Trust Division
Premier Asset Management LLC
Northern Trust Corp
Virtu Financial LLC
Nuveen Asset Management LLC
Hollencrest Capital Management

Which institutional investors are buying La Jolla Pharmaceutical stock?

During the previous quarter, LJPC stock was purchased by institutional investors including:

D. E. Shaw & Co. Inc.
Millennium Management LLC
Acadian Asset Management LLC
Bank of New York Mellon Corp
Squarepoint Ops LLC
WealthTrust Axiom LLC
Trexquant Investment LP
Morgan Stanley

Within the previous year, these company insiders have bought La Jolla Pharmaceutical stock:

David A Ramsay (Director)
Darryl Wellinghoff (Insider)
Kevin C Tang (Director)

To Any American Who Owns a Cell Phone

From Legacy Research | Ad

If you own a cell phone, then mobile service providers hope you never get to see this video that could soon go viral.

His experiment could strike a bad chord with mobile phone companies. But you’ve got to see what this man discovered and what it means for phone users in the weeks ahead.

Click here to see this video before it's removed